ClinVar Miner

Submissions for variant NM_004004.6(GJB2):c.-45C>A (rs397516868)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000037808 SCV000061470 benign not specified 2017-06-13 criteria provided, single submitter clinical testing c.-45C>A in Exon 1 of GJB2: This variant has been identified in 0.4%(58/14946) o f European chromosomes by the Genome Aggregation Database (gnomAD; http://gnoma d.broadinstitute.org; dbSNP rs397516868). Expression studies showed presence of the expressed GJB2 gene (Wilch 2006).
Illumina Clinical Services Laboratory,Illumina RCV000333575 SCV000383066 likely benign Mutilating keratoderma 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000387998 SCV000383067 likely benign Hystrix-like ichthyosis with deafness 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000293627 SCV000383068 likely benign Keratitis-Ichthyosis-Deafness Syndrome 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000330001 SCV000383069 likely benign Nonsyndromic Hearing Loss, Dominant 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000375249 SCV000383070 likely benign Nonsyndromic Hearing Loss, Recessive 2016-06-14 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000590296 SCV000698259 likely benign not provided 2017-04-13 criteria provided, single submitter clinical testing Variant summary: The GJB2 c.-45C>A variant is located in the 5' UTR causing an alteration of a non-conserved nucleotide. One in silico tool predicts a benign outcome for this variant. This variant was found in the large, broad control population, gnomAD with an allele frequency of 71/30972, which does not exceed the estimated maximal expected allele frequency of a pathogenic GJB2 variant (0.0259808) for an autosomal recessive mode of inheritance. It should be noted that the gnomAD dataset has yet to be validated by the LCA VSG, therefore, this observation needs to be cautiously considered at this time. An allele-based expression analysis showed presence of the expressed GJB2 gene (Wilch_2006) indicating the variant no to have an impact on protein expression. Furthermore, 3/4 publications classify the variant as polymorphism, which is supported by the evidence that the variant was observed in trans with a pathogenic allele in an unaffected individual, suggesting a lack of segregation with disease. In addition, two reputable sources (LMM and Deafness variation database) list this variant as 'likely benign'. Taken together, this variant is classified as "likely benign."
GeneDx RCV000037808 SCV000724451 likely benign not specified 2017-10-31 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Athena Diagnostics Inc RCV000590296 SCV000841709 likely benign not provided 2018-08-08 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.